Bio Farma

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
PT Bio Farma (Persero)
TypeState-owned PT
Founded6 August 1890 (1890-08-06) as Parc-vaccinogène
HeadquartersBandung, Indonesia
OwnersGovernment of Indonesia

PT Bio Farma (Persero) is an Indonesian state-owned enterprise based in Bandung and the only local vaccine manufacturer in Indonesia,[2] which produces vaccines and sera to support immunization in Indonesia and other countries.[3] Bio Farma vaccine produced vaccines against measles, polio, hepatitis B, and pentavalent vaccine.[2] Bio Farma vaccines have supplied vaccines to multiple countries through UNICEF, PAHO and other organizations.[4]


Vaccine vials in Bio Farma, 2017

Bio Farma's history began during the Dutch East Indies period, when the colonial government founded Parc-vaccinogène (State Vaccine Development Agency) on 6 August 1890. The agency occupied a building in Weltevreden – Batavia, which is now Gatot Soebroto Army Hospital. Since its inception, Parc-vaccinogène focused on eliminating infectious diseases, which leads to its cooperation with Pasteur Institute. Eventually, the agency was renamed to Parc-vaccinogène en Instituut Pasteur in 1895.[3]

During the administration of J.P. van Limburg Stirum, Hendrik Freerk Tillema recommended to move the capital of Dutch East Indies to Bandung due to its natural conditions and hilly terrain, making it easier to defend. The idea was gradually accepted and began to be implemented by the Dutch colonial government in early 1920s after it was supported by Prof. J. Kolopper, Rector of Technische Hoogeschool te Bandoeng at the time. Government and private offices along with other agencies began moving to Bandung, including the foreign trade office, salvation army, government bodies and Landskoepok Inrichling en Instituut Pasteur, which stayed in Bandung until the present day.[5]

The agency has experienced several changes in name and legal entity, which are as follows:[6]

Main Building of Bio Farma (2005)
  • 1890-1895 – Parc-vaccinogène
  • 1895-1901 – Parc-vaccinogène en Instituut Pasteur
  • 1902-1941 – Landskoepok Inrichling en Instituut Pasteur
  • 1942-1945 – Bandung Epidemics Institute (バンドン防疫研究所, Bandon Bōeki Kenkyūsho), under Japanese occupation
  • 1945-1949  – Gedung Cacar dan Lembaga Pasteur, after Indonesian independence. During the independence war, its activities moved to Klaten, Yogyakarta
  • 1946-1949 – Since Bandung is under Dutch control during the independence war, the name of the Bandung facility reverted to Landskoepok Inrichling en Instituut Pasteur
  • 1950-1954 – Gedung Cacar dan Lembaga Pasteur, Independence war is over and the agency returned to Bandung
  • 1955-1960 – Perusahaan Negara Pasteur
  • 1961-1978 – Perusahaan Negara Bio Farma
  • 1978-1997 – Perusahaan Umum Bio Farma
  • 1997–present  – PT Bio Farma (Persero)


  1. ^ a b Lane, EJ (21 October 2019). "Bio Farma becomes the controlling shareholder of KAEF an INAF". IDN Financials. Retrieved 23 December 2019.
  2. ^ a b Hadisoemarto, PF; Reich, MR; Castro, MC (2016). "Introduction of pentavalent vaccine in Indonesia: a policy analysis". Health Policy and Planning. Oxford University Press. 31 (8): 1079–1088. doi:10.1093/heapol/czw038. PMC 5013783. PMID 27107293.
  3. ^ a b "Bio Farma". kementerian BUMN. Retrieved 23 December 2019.
  4. ^ "Bio Farma profile". June 11, 2017.
  5. ^ Reitsma, S.A; Hoogland, W.H (1921). Gids van Bandongs on Omstreken. N.V. Mij Vorkink. p. 98.
  6. ^ "Sejarah dan Perkembangan PT Bio Farma (Persero)" (PDF). June 12, 2017.

External links[edit]